Q2 EPS Estimate for Procter & Gamble Reduced by Analyst

Key Points

• Zacks Research cut its Q2 2027 EPS estimate for Procter & Gamble to $1.80 from $1.88. It also forecast FY2027 EPS of $6.96 and FY2028 EPS of $7.41.
• Analyst views remain generally positive: 15 analysts rate the stock Buy and 11 Hold, giving it a consensus “Moderate Buy” rating and a $170.57 price target.
• P&G’s latest quarter beat expectations, reporting EPS of $2.00 versus $1.89 expected and revenue of $23.28 billion; revenue increased 4% year over year.

Procter & Gamble Company (The) (NYSE:PG - Free Report) - Equities researchers at Zacks Research cut their Q2 2027 earnings per share (EPS) estimates for shares of Procter & Gamble in a report issued on Thursday, November 5th. Zacks Research analyst Team now expects that the company will earn $1.80 per share for the quarter, down from their prior forecast of $1.88. The consensus estimate for Procter & Gamble's current full-year earnings is $6.99 per share. Zacks Research also issued estimates for Procter & Gamble's Q3 2027 earnings at $1.63 EPS, Q4 2027 earnings at $1.53 EPS, FY2027 earnings at $6.96 EPS, Q1 2028 earnings at $2.11 EPS, Q2 2028 earnings at $1.98 EPS, Q3 2028 earnings at $1.73 EPS, Q4 2028 earnings at $1.59 EPS, FY2028 earnings at $7.41 EPS, Q1 2029 earnings at $2.25 EPS and FY2029 earnings at $7.91 EPS.

Several other research firms also recently weighed in on PG. DZ Bank downgraded shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 27th. Evercore upgraded Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price target for the company in a research note on Tuesday, October 6th. HSBC lowered Procter & Gamble from a "buy" rating to a "hold" rating and lowered their price objective for the company from $182.00 to $149.00 in a report on Thursday, July 30th. Argus cut Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Friday, August 7th. Finally, UBS Group set a $166.00 target price on Procter & Gamble in a report on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $170.57.

Procter & Gamble Trading Down 0.1%

NYSE PG opened at $167.15 on Friday. Procter & Gamble has a 12 month low of $137.62 and a 12 month high of $170.52. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. The company has a market capitalization of $387.41 billion, a price-to-earnings ratio of 25.17, a price-to-earnings-growth ratio of 4.11 and a beta of 0.36. The company's fifty day moving average price is $151.56 and its two-hundred day moving average price is $149.34.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business's quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.99 earnings per share.

Institutional Trading of Procter & Gamble

A number of institutional investors and hedge funds have recently made changes to their positions in PG. Baxter Bros Inc. bought a new position in Procter & Gamble in the second quarter valued at approximately $12,381,000. Empowered Funds LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $53,549,000. Capstone Capital Management Ltd bought a new stake in Procter & Gamble during the third quarter worth $991,000. Bank of America Corp DE bought a new stake in Procter & Gamble during the second quarter worth $3,850,628,000. Finally, Rokos Capital Management LLP acquired a new stake in shares of Procter & Gamble in the 1st quarter valued at $29,914,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Victor Aguilar sold 18,812 shares of the stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $164.43, for a total transaction of $3,093,257.16. Following the sale, the insider owned 55,243 shares in the company, valued at $9,083,606.49. This represents a 25.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 33,624 shares of the firm's stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $165.00, for a total transaction of $5,547,960.00. Following the completion of the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at $10,826,970. This represents a 33.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 161,709 shares of company stock worth $26,244,058. Company insiders own 0.23% of the company's stock.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble's dividend payout ratio (DPR) is presently 65.51%.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Zacks Research raised its FY2029 EPS estimate to $7.91 from $7.85 and lifted its Q1 2028 and Q1 2029 forecasts. The longer-term increases provide a modest positive counterpoint to reductions in other periods.
• Positive Sentiment: P&G’s latest reported quarter beat analyst expectations for earnings and revenue, with sales up 4% year over year. Demand for dependable dividend-paying consumer-staples stocks has also supported interest in the shares.
• Neutral Sentiment: P&G will webcast its November 19 Investor Day, where executives are expected to discuss strategy and the company’s long-term transformation. Investors may look for updates on growth plans and execution. Article: P&G Investor Day webcast
• Negative Sentiment: Zacks Research trimmed several nearer-term estimates, including FY2027 EPS to $6.96 from $6.97 and FY2028 to $7.41 from $7.42; multiple quarterly forecasts for 2027–28 were also reduced. The small cuts suggest somewhat softer expectations for those periods.
• Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct holding by roughly 34%. Insider sales can weigh on sentiment, though they do not necessarily indicate a change in the company’s outlook. Article: CFO share sale

Procter & Gamble Company Profile

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.